The Maximally Tolerated Dose: The Key Context for Interpreting Subtarget Medication Dosing for Heart Failure.
Publication
, Journal Article
Greene, SJ; DeVore, AD
Published in: JACC Heart Fail
September 2020
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
JACC Heart Fail
DOI
EISSN
2213-1787
Publication Date
September 2020
Volume
8
Issue
9
Start / End Page
739 / 741
Location
United States
Related Subject Headings
- Stroke Volume
- Maximum Tolerated Dose
- Humans
- Heart Failure
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Greene, S. J., & DeVore, A. D. (2020). The Maximally Tolerated Dose: The Key Context for Interpreting Subtarget Medication Dosing for Heart Failure. JACC Heart Fail, 8(9), 739–741. https://doi.org/10.1016/j.jchf.2020.05.011
Greene, Stephen J., and Adam D. DeVore. “The Maximally Tolerated Dose: The Key Context for Interpreting Subtarget Medication Dosing for Heart Failure.” JACC Heart Fail 8, no. 9 (September 2020): 739–41. https://doi.org/10.1016/j.jchf.2020.05.011.
Greene SJ, DeVore AD. The Maximally Tolerated Dose: The Key Context for Interpreting Subtarget Medication Dosing for Heart Failure. JACC Heart Fail. 2020 Sep;8(9):739–41.
Greene, Stephen J., and Adam D. DeVore. “The Maximally Tolerated Dose: The Key Context for Interpreting Subtarget Medication Dosing for Heart Failure.” JACC Heart Fail, vol. 8, no. 9, Sept. 2020, pp. 739–41. Pubmed, doi:10.1016/j.jchf.2020.05.011.
Greene SJ, DeVore AD. The Maximally Tolerated Dose: The Key Context for Interpreting Subtarget Medication Dosing for Heart Failure. JACC Heart Fail. 2020 Sep;8(9):739–741.
Published In
JACC Heart Fail
DOI
EISSN
2213-1787
Publication Date
September 2020
Volume
8
Issue
9
Start / End Page
739 / 741
Location
United States
Related Subject Headings
- Stroke Volume
- Maximum Tolerated Dose
- Humans
- Heart Failure
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology